Position in INVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,480,346
+$927,252 QoQ
Shares Held
549,553
+10.8% QoQ
Ownership
0.761%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. INVA ranks #44 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in INVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,480,346 | 549,553 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $11,553,094 | 495,841 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $7,418,506 | 371,111 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,520,113 | 302,472 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,952,806 | 196,755 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $3,035,975 | 167,456 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,466,110 | 142,139 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,023,443 | 156,574 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,875,067 | 175,309 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,678,475 | 175,753 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,197,574 | 199,350 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,016,832 | 309,225 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,563,017 | 358,446 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,004,012 | 533,690 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,332,740 | 402,471 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,439,009 | 296,211 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,235,092 | 151,429 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,536,204 | 131,070 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,245,398 | 130,168 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,961,770 | 117,401 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,631,581 | 121,669 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,604,024 | 134,228 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,349,280 | 189,611 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,864,948 | 178,464 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,043,865 | 217,730 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $2,703,812 | 229,916 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||